Surgical treatment of Primary palmar hyperhidrosis
Conditions
Interventions
Experimental group:Unilateral R3 thoracic sympathectomy
Control group:Bilateral R3 thoracic sympathectomy
Sponsors
The Third People's Hospital Of Shenzhen
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients with multiple sites of moderate to severe primary hyperhidrosis who are willing to undergo surgery, specifically manifested as patients with hand hyperhidrosis accompanied by sweating on the feet, underarms or face. (2) Age 15-65 years old. (3) Patients who understand and accept postoperative compensatory sweating and recurrence of postoperative hand sweating.
Exclusion criteria
Exclusion criteria: (1) Patients with recent tuberculosis, malignant tumor, hyperthyroidism and other endocrine diseases or hypothalamic central diseases. (2) Patients with autoimmune vasculitis, thoracic outlet syndrome, empyema and tuberculosis in the past caused dense adhesions of the pleura. (3) Serious bradycardia with electrocardiogram heart rate New York Heart Association (NYHA) class II. Lung function: FEV1<1.5L, MVV<50% of predicted value. (7) Those who have poor compliance and cannot complete the planned follow-up. 8. Patients considered by the investigator to be unsuitable for participating in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hyperhidrosis relief degree; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment effect evaluation;Patient satisfaction; | — |
Countries
China
Contacts
Public ContactShi Qinlang
The Third People's Hospital Of Shenzhen
Outcome results
None listed